We are live on
!
Find out more
RP
Rice Partnership Portfolio holdings
AUM
$824M
1-Year Est. Return
40.45%
This Fund
S&P 500
This Quarter
Est. Return
-14.33%
1 Year Est. Return
+40.45%
3 Year Est. Return
+123.46%
5 Year Est. Return
+159.59%
10 Year Est. Return
–
AUM
$285M
AUM Growth
-$61.6M
(-18%)
Cap. Flow
-$6.84M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
44.57%
Holding
135
New
4
Increased
31
Reduced
40
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.51M |
| 2 |
Coca-Cola
KO
|
+$1.98M |
| 3 |
Sempra
SRE
|
+$1.95M |
| 4 |
IBM
IBM
|
+$1.88M |
| 5 |
iShares MSCI India ETF
INDA
|
+$673K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$2.14M |
| 2 |
Walmart Inc
WMT
|
+$1.58M |
| 3 |
Eaton
ETN
|
+$1.42M |
| 4 |
Prologis
PLD
|
+$1.32M |
| 5 |
NextEra Energy
NEE
|
+$1.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.51% |
| 2 | Healthcare | 15.19% |
| 3 | Consumer Discretionary | 8.45% |
| 4 | Financials | 8.26% |
| 5 | Consumer Staples | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares Biotechnology ETF
IBB
$9.18B
| – | – |
-300
| Closed | -$39K |
|
127
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
| – | – |
-4,436
| Closed | -$215K |
|
128
Plug Power
PLUG
$2.9B
| – | – |
-12,300
| Closed | -$352K |
|
129
Rio Tinto
RIO
$156B
| – | – |
-3,000
| Closed | -$241K |
|
|
SCHR
130
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $0 | ﹤0.01% |
14
+10
| +250% | +$259 |
|
131
Steris
STE
$22.7B
| – | – |
-935
| Closed | -$226K |
|
132
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
| – | – |
-695
| Closed | -$73K |
|
133
iShares TIPS Bond ETF
TIP
$14.5B
| – | – |
-37
| Closed | -$5K |
|
134
Toyota
TM
$220B
| – | – |
-5,881
| Closed | -$1.06M |
|
|
WCN
135
Waste Connections
WCN
$42.3B
| – | – |
-1,508
| Closed | -$211K |
|
Similar funds
MA
SCM
VT
FPCP
CCM
AC
DI
FSA
Rice Partnership's Q2 2022 Portfolio in Review
As of Q2 2022, Rice Partnership held 135 positions worth $285M, down 18% from $347M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Rice Partnership's Q2 2022 filing shows 4 new, 31 increased, 40 reduced and 17 closed positions. Its largest new stake was Sempra: 24,268 shares worth $1.82M. The largest sale was Abbott, an estimated $2.14M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Rice Partnership's largest Q2 2022 buy was Sempra: 24,268 shares worth $1.82M.
- Rice Partnership added most to UnitedHealth in Q2 2022, an estimated $2.51M increase.
- Rice Partnership's biggest Q2 2022 reduction was Abbott, cutting an estimated $2.14M.
- Rice Partnership fully exited Toyota in Q2 2022, selling an estimated $1.06M.
- Rice Partnership's ten largest holdings make up 45% of its $285M portfolio in Q2 2022.
- Rice Partnership opened 4 new positions and closed 17 in Q2 2022.
- Rice Partnership's portfolio value fell 18% quarter-over-quarter to $285M.
Based on Rice Partnership's 13F filing for Q2 2022, filed 22 Jul 2022.